Madeleine Farman
Madeleine Farman is the editor of PEI Group’s Secondaries Investor title based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
The European buyout firm moved Sunrise Medical into a landmark €2.5bn multi-asset continuation vehicle six years ago.
Crown Secondaries Special Opportunities III has closed on $3bn ahead of its $2.5bn target.
Predecessor vehicle Fund IV is over 75% invested and has a TVPI of 1.5x, according to documents prepared for a US state investor.
Amid the broadening supply of private wealth-focused evergreen vehicles, ICG and Dawson Partners are the latest managers to join the fold with funds focused on secondaries.
Public Investment Fund is an LP in Ardian’s predecessor vehicle, which closed on $14bn in 2020 ahead of its $12bn target.
Michael Camacho, a former long-time AlpInvest Partners executive who has worked in North America, Europe and Asia, is understood to be leaving this week.
The USS sale marks the latest sizeable LP-led portfolio that Partners Group has backed in recent months.
In this sixth episode of the Decade of Secondaries Investing podcast miniseries, we sit down with HarbourVest Partners' Jeffrey Keay and PJT Park Hill's Adrian Millan to discuss the phenomenon of repeat sellers in the secondaries market.
While impact secondaries transactions remain a relatively small part of overall secondaries volume, these vehicles can offer more certainty around impact-linked growth stories compared with their blind-pool counterparts.
Iron Road Partners’ Igor Rozenblit – former co-head of the SEC's private funds unit – details concerns and red flags the regulator will be looking for following the passing of its private market rules last year.